BlackBox Bio provides automated platforms for in vivo behavioral analysis in research settings. Their software utilizes machine learning algorithms to automate the measurement of rodent behavior, including posture, weight bearing, and gait analysis. This high-throughput screening enables researchers to gain deeper, more reproducible insights from their experimental data.
Funding
Funding not disclosed
Founders
Product
Problem
Rodent behavioral phenotyping and in vivo screening of psychoactive compounds are traditionally time-consuming and labor-intensive processes. Manual observation and analysis can introduce bias and limit the throughput of drug discovery efforts.
Solution
Blackbox Bio offers an automated platform for rodent behavioral phenotyping and high-throughput in vivo screening of psychoactive medicinal compounds. The system employs advanced imaging technologies to continuously monitor and record rodent behavior in a controlled environment. Proprietary algorithms then analyze the collected data to extract quantitative behavioral metrics, providing researchers with objective and reproducible results. This automated approach accelerates drug discovery by enabling rapid assessment of compound efficacy in preclinical models, while reducing the need for manual observation and analysis.
Target Audience
The primary audience includes pharmaceutical companies, biotechnology firms, and academic research institutions involved in drug discovery and preclinical research.
Features
- Automated video tracking and behavioral analysis
- High-throughput screening capabilities for in vivo studies
- Quantitative behavioral metrics for objective data analysis
- Controlled environment for consistent and reproducible results